The FDA's orphan drug designation supports LP-284's development for soft tissue sarcomas, addressing significant unmet needs in this adult patient population. The FDA granted orphan drug designation ...
A whole-genome sequencing approach shows early promise over current commercial methods for identifying more patients likely ...
Changes in genes have been linked to the development of different diseases for a while. However, it's not exactly clear what ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback